Shanghai Yizhong announced that Shanghai Youxichuang Pharmaceutical Technology Co., Ltd., a wholly-owned subsidiary of the company, recently received the “Drug Clinical Trial Approval Notice” issued by the State Drug Administration, and the clinical trial application of the company's self-developed innovative drug YXC-001 for the treatment of advanced solid tumors has been officially approved.

Zhitongcaijing · 1d ago
Shanghai Yizhong announced that Shanghai Youxichuang Pharmaceutical Technology Co., Ltd., a wholly-owned subsidiary of the company, recently received the “Drug Clinical Trial Approval Notice” issued by the State Drug Administration, and the clinical trial application of the company's self-developed innovative drug YXC-001 for the treatment of advanced solid tumors has been officially approved.